Tag: #Lp(a)

Introduction Recurrent cardiac events in patients with elevated Lipoprotein(a) [Lp(a)] levels remain a significant challenge in cardiovascular management. The featured case study explores how prothrombotic burden and genetic predispositions can influence outcomes even under advanced therapies like lipoprotein apheresis. This insightful clinical report underscores the importance of personalized cardiovascular risk assessment.For more authoritative medical insights,…